Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?
- 26 May 2020
- journal article
- editorial
- Published by Taylor & Francis Ltd in Expert Opinion on Biological Therapy
- Vol. 20 (8), 831-836
- https://doi.org/10.1080/14712598.2020.1767062
Abstract
Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?. Expert Opinion on Biological Therapy. Accepted 6 May 2020.Funding Information
- CONACyT (CB283319 and UNAM-PAPIIT-IN-223319)
This publication has 37 references indexed in Scilit:
- Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brainVirology Journal, 2012
- Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid ProteinMolecular Pharmaceutics, 2012
- Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responsesBMC Immunology, 2010
- The M Cell-Targeting Ligand Promotes Antigen Delivery and Induces Antigen-Specific Immune Responses in Mucosal VaccinationThe Journal of Immunology, 2010
- Effect of mucosal and systemic immunization with virus‐like particles of severe acute respiratory syndrome coronavirus in miceImmunology, 2010
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- A Novel Replication-Competent Vaccinia Vector MVTT Is Superior to MVA for Inducing High Levels of Neutralizing Antibody via Mucosal VaccinationPLOS ONE, 2009
- A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirusVaccine, 2008
- Regulation of immunological homeostasis in the respiratory tractNature Reviews Immunology, 2008
- Type IVB Pilus Operon Promoter Controlling Expression of the Severe Acute Respiratory Syndrome-Associated Coronavirus Nucleocapsid Gene in Salmonella enterica Serovar Typhi Elicits Full Immune Response by Intranasal VaccinationClinical and Vaccine Immunology, 2007